Anal carcinoma in HIV-infected patients in the era of antiretroviral therapy: A comparative study

Diseases of the Colon and Rectum

Volumn 54, Issue 6, 2011, Pages 729-735

  Munoz Bongrand, Nicolas ^a   Poghosyan, Tigran ^a   Zohar, Sarah ^a   Gerard, Laurence ^a   Chirica, Mircea ^a   Quero, Laurent ^a   Gornet, Jean Marc ^a   Cattan, Pierre ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Anal squamous cell carcinoma; HIV AIDS; Radiation oncology; Surgical oncology; Treatment outcome.

Indexed keywords

CISPLATIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; ANTINEOPLASTIC AGENT;

ADULT; AGED; ANUS CARCINOMA; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER INVASION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL EVALUATION; COLOSTOMY; COMPARATIVE STUDY; CONTINUOUS INFUSION; DEATH; FECES INCONTINENCE; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IRRADIATION; MALE; OVERALL SURVIVAL; RECTOVAGINAL FISTULA; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; TREATMENT FAILURE; VAGINA DISEASE; VIRUS LOAD; ANUS TUMOR; CHI SQUARE DISTRIBUTION; FRANCE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; NONPARAMETRIC TEST; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; ANUS NEOPLASMS; CHI-SQUARE DISTRIBUTION; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; FRANCE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; SURVIVAL RATE; VIRAL LOAD;

EID: 79960948930     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1007/DCR.0b013e3182137de9     Document Type: Article

References (28)

1. Chiao EY, Giordano TP, Richardson P, El-Serag HB. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol. 2008;26:474-479. (Pubitemid 351171702)
2. Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet. 2007;370:59-67. (Pubitemid 47017468)
3. Powles T, Robinson D, Stebbing J, et al. Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. J Clin Oncol. 2009;27:884-890.
4. Blazy A, Hennequin C, Gornet JM, et al. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum. 2005;48:1176-1181. (Pubitemid 40897861)
5. Piketty C, Selinger-Leneman H, Grabar S, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS. 2008;22:1203-1211.
6. Nadal SR, Manzione CR, Horta SH. Comparison of perianal diseases in HIV-positive patients during periods before and after protease inhibitors use: what changed in the 21st century. Dis Colon Rectum. 2008;51:1491-1494.
7. Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med. 2003;138:453-459.
8. Ryan DP, Compton CC, Mayer RJ. Carcinoma of the anal canal. N Engl J Med. 2000;342:792-800. (Pubitemid 30151924)
9. Bartelink H, Roelofsen F, Eschwege F, et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol. 1997;15:2040-2049. (Pubitemid 27209535)
10. Deniaud-Alexandre E, Touboul E, Tiret E, et al. Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin) [in French]. Cancer Radiother. 2006;10:572-582. (Pubitemid 44895596)
11. Vatra B, Sobhani I, Aparicio T, et al. Anal canal squamous-cell carcinomas in HIV positive patients: clinical features, treatments and prognosis [in French]. Gastroenterol Clin Biol. 2002; 26:150-156. (Pubitemid 34267134)
12. Kim JH, Sarani B, Orkin BA, et al. HIV-positive patients with anal carcinoma have poorer treatment tolerance and outcome than HIV-negative patients. Dis Colon Rectum. 2001;44:1496-1502. (Pubitemid 32952556)
13. Wexler A, Berson AM, Goldstone SE, et al. Invasive anal squamous- cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy. Dis Colon Rectum. 2008;51:73-81.
14. Oehler-Janne C, Seifert B, Lutolf UM, Ciernik IF. Local tumor control and toxicity in HIV-associated anal carcinoma treated with radiotherapy in the era of antiretroviral therapy. Radiat Oncol. 2006;1:29.
15. Bell SW, Dehni N, Chaouat M, et al. Primary rectus abdominis myocutaneous flap for repair of perineal and vaginal defects after extended abdominoperineal resection. Br J Surg. 2005;92: 482-486. (Pubitemid 40523914)
16. Ghouti L, Houvenaeghel G, Moutardier V, et al. Salvage abdominoperineal resection after failure of conservative treatment in anal epidermoid cancer. Dis Colon Rectum. 2005;48:16-22. (Pubitemid 40895652)
17. Grambsch P, Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515-526.
18. Crum-Cianflone N, Hullsiek KH, Marconi V, et al. Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study. AIDS. 2009;23:41-50.
19. Abramowitz L, Benabderrahmane D, Ravaud P, et al. Anal squamous intraepithelial lesions and condyloma in HIV-infected heterosexual men, homosexual men and women: prevalence and associated factors. AIDS. 2007;21:1457-1465. (Pubitemid 46988006)
20. Oehler-Janne C, Huguet F, Provencher S, et al. HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy. J Clin Oncol. 2008; 26:2550-2557.
21. Guiguet M, Boue F, Cadranel J, et al. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study. Lancet Oncol. 2009;10:1152-1159.
22. Hogg ME, Popowich DA, Wang EC, et al. HIV and anal cancer outcomes: a single institution's experience. Dis Colon Rectum. 2009;52:891-897.
23. Roohipour R, Patil S, Goodman KA, et al. Squamous-cell carcinoma of the anal canal: predictors of treatment outcome. Dis Colon Rectum. 2008;51:147-153.
24. Stadler RF, Gregorcyk SG, Euhus DM, et al. Outcome of HIVinfected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy. Dis Colon Rectum. 2004;47:1305-1309. (Pubitemid 39180205)
25. Lefevre JH, Parc Y, Kerneis S, et al. Abdomino-perineal resection for anal cancer: impact of a vertical rectus abdominis myocutaneus flap on survival, recurrence, morbidity, and wound healing. Ann Surg. 2009;250:707-711.
26. Glynne-Jones R, Northover JM, Cervantes A. Anal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010;21 Suppl 5:v87-92.
27. Ajani JA, Winter KA, Gunderson LL, et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008;299:1914-1921. (Pubitemid 351574921)
28. Salama JK, Mell LK, Schomas DA, et al. Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience. J Clin Oncol. 2007;25: 4581-4586. (Pubitemid 350035316)